diseas
associ
pneumonia
patient
method
retrospect
cohort
studi
patient
moderatetocrit
associ
pneumonia
requir
oxygen
satur
spo
measur
test
predictor
inhospit
mortal
surviv
analysi
patient
associ
pneumonia
men
median
age
year
patient
spo
older
like
men
hypertens
present
dyspnea
spo
overal
patient
die
hospit
median
followup
higher
postoxygen
supplement
spo
level
associ
reduc
mortal
independ
age
sex
hazard
ratio
per
spo
confid
interv
p
spo
cutoff
yield
sensit
specif
predict
surviv
dyspnea
also
independ
associ
death
multivari
analysi
hazard
ratio
confid
interv
p
cohort
patient
hypoxemia
independ
associ
inhospit
mortal
result
may
help
guid
clinic
manag
sever
patient
particularli
set
requir
strateg
alloc
limit
critic
care
resourc
abbrevi
auc
area
curv
ci
confid
interv
copd
chronic
obstruct
pulmonari
diseas
coronaviru
diseas
crp
creactiv
protein
ct
comput
tomographi
hr
hazard
ratio
iqr
interquartil
rang
roc
receiveroper
characterist
spo
oxygen
satur
wbc
white
blood
cell
coronaviru
diseas
outbreak
pandem
strain
medic
infrastructur
personnel
resourc
much
europ
middl
east
north
america
signific
consequ
clinic
manag
includ
ration
care
contemporari
statist
indic
associ
pneumonia
case
sever
infect
patient
requir
intens
care
mortal
rate
sever
critic
ill
patient
stagger
diseas
fatal
approxim
twothird
given
limit
avail
critic
care
resourc
imper
identifi
simpl
reliabl
predictor
surviv
patient
present
least
moder
diseas
sever
thu
sought
identifi
compar
differenti
predict
valu
demograph
clinic
laboratori
measur
moderatetocrit
ill
patient
wuhan
china
sinc
primarili
attack
respiratori
system
measur
reflect
respiratori
function
would
like
relat
outcom
particularli
rapidli
progress
diseas
condit
therefor
focus
particularli
dyspnea
system
oxygen
potenti
prognost
biomark
singlecent
retrospect
cohort
studi
enrol
patient
moderatetocrit
associ
pneumonia
hospit
treat
beij
medic
team
union
hospit
wuhan
januari
th
februari
th
followup
march
th
beij
medic
team
consist
physician
volunt
beij
dr
xie
gao
beij
anzhen
hospit
institut
review
board
approv
studi
nation
health
committe
peopl
republ
china
recommend
diagnosi
associ
pneumonia
use
patient
includ
studi
met
follow
criteria
confirm
infect
base
realtim
revers
transcriptas
polymeras
chain
reaction
rtpcr
test
throat
swab
sampl
object
evid
newonset
pneumonia
chest
comput
tomographi
ct
scan
typic
symptom
pneumonia
ie
fever
cough
dyspnea
etc
pneumonia
sever
grade
moder
sever
critic
diseas
sever
defin
accord
classif
propos
chines
guidelin
associ
pneumonia
mention
supplement
tabl
moder
case
present
typic
symptom
pneumonia
ie
fever
cough
expector
dyspnea
definit
lesion
confirm
ct
scan
sever
case
met
follow
criteria
respiratori
rate
oxygen
satur
spo
rest
pressur
arteri
oxygen
fraction
inspir
oxygen
concentr
progress
lesion
evid
ct
scan
past
hour
lastli
associ
pneumonia
case
regard
critic
satisfi
follow
intub
need
due
respiratori
failur
shock
multipl
organ
dysfunct
requir
intens
care
unit
treatment
patient
high
clinic
suspicion
associ
pneumonia
name
definit
epidemiolog
exposur
famili
breakout
aforement
featur
clinic
diagnos
specialist
team
hospit
quarantin
zone
includ
studi
despit
absenc
document
confirm
nucleic
acid
screen
importantli
regard
appropri
recent
concern
inclus
patient
differ
report
awar
one
prior
studi
patient
union
hospit
may
includ
approxim
patient
current
studi
event
paper
make
mention
key
find
studi
name
role
dyspnea
hypoxemia
predictor
mortal
patient
treat
follow
chines
guidelin
although
antibiot
recommend
routin
treatment
still
consid
patient
found
evid
definit
suspect
bacteri
infect
abund
purul
sputum
base
clinic
assess
respons
physician
depend
diseas
sever
clinic
assess
patient
hospit
oxygen
supplement
nasal
cannula
administ
patient
directli
admiss
oxygen
flow
rang
low
lmin
high
flow
lmin
vari
per
patient
respons
goal
maintain
peripher
oxygen
satur
spo
postoxygen
supplement
spo
measur
finger
oximetri
minut
begin
oxygen
support
spo
fell
high
flow
oxygen
supplement
mask
high
nasal
flow
mechan
ventil
consid
need
demograph
clinic
characterist
collect
patient
patient
rel
physic
examin
medic
record
blood
measur
white
blood
cell
wbc
count
neutrophil
lymphocyt
platelet
creactiv
protein
crp
ddimer
acquir
date
death
obtain
registr
verifi
review
medic
record
followup
durat
comput
time
interv
day
date
admiss
date
death
date
discharg
whichev
occur
first
stabl
patient
remain
hospit
end
followup
period
regard
aliv
continu
data
report
median
interquartil
rang
iqr
categor
data
express
frequenc
percentag
wilcoxon
sign
ranktest
pearson
chisquar
test
use
compar
continu
categor
data
patient
postoxygen
supplement
spo
vs
spo
respect
surviv
calcul
kaplanmei
method
logrank
test
use
exposur
spo
dyspnea
demograph
clinic
characterist
univari
multivari
ageand
sexadjust
cox
proport
hazard
model
run
associ
express
hazard
ratio
hr
confid
interv
ci
use
receiveroper
characterist
roc
analysi
determin
optim
cutoff
postoxygen
supplement
spo
predict
surviv
base
threshold
yield
best
combin
sensit
specif
statist
analysi
perform
use
jmp
version
sa
institut
cari
nc
twosid
p
consid
signific
gener
patient
consid
high
likelihood
associ
classifi
critic
upon
admiss
vs
p
regard
treatment
antibiot
vs
p
high
nasal
flow
vs
p
commonli
administ
patient
spo
mechan
ventil
administ
patient
group
analysi
laboratori
biomark
show
wbc
count
neutrophil
crp
ddimer
higher
lymphocyt
platelet
lower
patient
spo
vs
spo
age
year
hr
ci
p
male
sex
hr
ci
p
hypertens
hr
ci
p
presenc
comorbid
defin
least
one
comorbid
among
shown
tabl
hr
ci
p
associ
mortal
univari
analysi
figur
ad
tabl
presenc
comorbid
remain
signific
risk
factor
associ
death
adjust
age
sex
hr
ci
p
report
dyspnea
initi
symptom
like
die
report
figur
vs
logrank
p
hr
ci
p
tabl
thirtyf
patient
postoxygen
supplement
spo
surviv
logrank
p
figur
model
spo
continu
variabl
cox
model
found
increas
spo
mortal
risk
decreas
approxim
hr
ci
p
dyspnea
spo
significantli
associ
outcom
multivari
model
hr
ci
p
hr
p
respect
tabl
notabl
sensit
analysi
restrict
patient
confirm
infect
base
rtpcr
test
show
independ
associ
dyspnea
death
persist
sampl
hr
ci
p
patient
spo
die
spo
also
strongli
associ
death
independ
age
sex
multivari
hr
ci
p
roc
analysi
show
spo
optim
sao
cutoff
point
predict
surviv
demonstr
sensit
specif
accuraci
overal
area
curv
auc
figur
subgroup
analysi
patient
year
patient
die
year
old
patient
spo
n
supplement
oxygen
surviv
laboratori
biomark
prove
associ
mortal
kaplanmei
method
figur
ad
univari
cox
regress
analysi
data
provid
insight
risk
factor
mortal
rel
larg
sampl
moder
critic
ill
patient
associ
pneumonia
line
prior
report
data
confirm
age
sex
comorbid
inflammatori
biomark
associ
mortal
demonstr
novel
clinic
import
find
independ
deathassoci
valu
two
simpl
yet
readili
assess
characterist
name
dyspnea
hypoxemia
spo
despit
oxygen
supplement
found
dyspnea
easili
assess
symptom
associ
death
patient
associ
pneumonia
independ
age
sex
howev
relat
also
easili
acquir
clinic
measur
oxygen
satur
despit
oxygen
supplement
provid
robust
risk
factor
fatal
outcom
inde
measur
power
predictor
multipl
measur
obtain
includ
standard
demograph
inflammatori
measur
report
earlier
studi
find
import
prognost
valu
dyspnea
hypoxemia
hospit
patient
associ
pneumonia
provid
rational
appli
standard
score
strategi
estim
risk
guid
treatment
even
patient
popul
ie
scale
pneumonia
sever
index
acut
physiolog
chronic
health
evalu
ii
futur
studi
assess
prognost
signific
model
associ
pneumonia
need
import
note
exploratori
subgroup
analysi
patient
year
older
mortal
known
especi
high
studi
reveal
patient
oxygen
satur
n
surviv
although
result
must
interpret
caution
given
small
sampl
size
possibl
confound
effect
age
may
especi
relev
consid
limit
access
care
area
overwhelm
case
older
age
possibl
use
triag
criterion
care
priorit
sever
hypoxemia
associ
pronounc
elev
inflammatori
marker
higher
wbc
count
neutrophil
count
ddimer
crp
acut
inflamm
respiratori
system
caus
respiratori
viru
andor
secondari
bacteri
infect
may
mechanist
respons
signific
pulmonari
injuri
thu
persist
hypoxemia
whether
attenu
inflammatori
respons
earli
diseas
would
improv
oxygen
possibl
surviv
remain
determin
acknowledg
studi
limit
small
minor
patient
neg
rtpcr
test
infect
despit
high
clinic
probabl
associ
pneumonia
base
clinic
radiograph
assess
epidemiolog
exposur
proport
unconfirm
case
consist
report
sensit
data
rtpcr
test
presum
fals
neg
robust
find
support
result
sensit
analysi
show
dyspnea
spo
remain
independ
associ
mortal
sampl
includ
patient
confirm
rtpcr
test
second
data
acquir
emerg
situat
oper
crisi
condit
mani
contemporan
studi
wuhan
therefor
complet
data
record
particularli
time
admiss
less
optim
exampl
oxygen
supplement
admiss
administ
goal
achiev
spo
specif
amount
oxygen
supplement
administ
patient
upon
admiss
record
therefor
incorpor
comparison
administ
inspir
oxygen
concentr
analys
similarli
recogn
dyspnea
inher
limit
subject
consist
data
rel
dyspnea
sever
time
intubationhigh
flow
time
mechan
ventil
chang
spo
hospit
avail
impact
variabl
outcom
patient
warrant
investig
report
moderatetocrit
ill
patient
oxygen
satur
oxygen
supplement
indic
high
likelihood
surviv
patient
thu
receiv
maxim
support
care
acut
ill
specul
patient
oxygen
satur
despit
oxygen
supplement
particularli
high
mortal
risk
may
like
benefit
experiment
therapi
investig
drug
antibodi
therapi
data
present
median
rang
n
follow
variabl
miss
data
wbc
neutrophil
count
lymphocyt
count
platelet
count
crp
ddimer
presenc
comorbid
defin
presenc
one
follow
chronic
diseas
hypertens
diabet
cardiovascular
diseas
chronic
obstruct
pulmonari
diseas
asthma
endstag
renal
failur
abbrevi
copd
chronic
obstruct
pulmonari
diseas
coronaviru
diseas
crp
creactiv
protein
spo
oxygen
satur
wbc
white
blood
cell
abbrevi
ci
confid
interv
coronaviru
diseas
crp
creactiv
protein
hr
hazard
ratio
spo
oxygen
satur
wbc
white
blood
cell
count
